HighGravityData
Companies / Labcorp / Filing

Labcorp — Apr 30, 2026 release

Fiscal 2026 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000920148-26-000135
Open on SEC.gov ↗
Showing in the filing
Quarterly cash dividend
“$0.72 per share”
Period
FY2026
Measure
Declared action
Source
Prose
All guidance in this release · 8
Enterprise Revenue for FY2026
“5.0% to 6.1%”
Adjusted EPS for FY2026
“$17.70 to $18.35”
Adjusted EPS midpoint for FY2026
“$18.03”
Quarterly cash dividend for FY2026
“$0.72 per share”
Labcorp Enterprise Revenue for FY2026
“$14.65 $14.80”
Diagnostics Laboratories Revenue for FY2026
“$11.43 $11.52”
Biopharma Laboratory Services Revenue for FY2026
“$3.22 $3.27”
Free Cash Flow for FY2026
“$1.24 $1.36”
Exhibit 99.1 · the passage around this item
… earlier in the release
In the first quarter of 2026, the company invested $202.2 million in acquisitions, repurchased $98.0 million of stock, and paid out $61.2 million in dividends. On April 9, 2026, the company announced a quarterly cash dividend of $0.72 per share of common stock, payable on June 11, 2026, to stockholders of record at the close of business on May 29, 2026. 2 LABCORP HOLDINGS INC. AND SUBSIDIARIES CONSOLIDATED RESULTS Three Months Ended March 31, 2026 2025 Delta Revenue Summary (Dollars in billions) Total Revenue $ 3.54  $ 3.35  5.8 % Organic (1) 3.1 % Acquisitions, net of Divestitures (2) 1.4 % Foreign Exchange 1.3 % (1) Excludes the impact from acquisitions, divestitures, and currency, as well as other strategic actions taken in Early Development. (2) Includes the impact from strategic actions taken in Early Development. Earnings Summary (Dollars in millions, except per share data) Operating Income (“OI”) $ 380.8  $ 326.0  OI as % of Revenue 10.8  % 9.7  % 100 bps Adjustments (3) $ 127.1  $ 143.0  Adjusted Operating Income (“AOI”) (4) $ 507.9  (5) $ 469.0  AOI as % of Revenue 14.4  % (5) 14.0  % 30 bps Net Earnings Attributable to Labcorp Holdings Inc. $ 277.8  $ 212.8  Diluted EPS $ 3.35  $ 2.52  Adjusted EPS (4) $ 4.25  $ 3.84  10.6  % (3) Adjustments include amortization, impairment charges, restructuring charges, and special items. (4) Non-GAAP financial measure. See “Reconciliation of Non-GAAP Measures” for additional
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.